Synthetic ABR Signal Generation Project -
Article Structure Guidelines

# Title

- Concise, technical, and informative.
- Include both synthetic ABR generation and
  methodology (e.g., CVAE, Diffusion, Transformer).
- Example: 'A Hybrid Diffusion–State Space
  Model for Synthetic Auditory Brainstem Response Signal Generation with Static
  Parameter Conditioning'.

# Abstract

- Length: ~250 words.
- Structure: Background, Objective,
  Methods, Results, Conclusion.
- Highlight clinical need, novelty of
  approach, key findings, and contribution.

# Keywords

- Include 5–7 keywords.
- Examples: Auditory Brainstem Response,
  Synthetic Data, Diffusion Model, State-Space Models, Time Series Generation,
  Hearing Loss Diagnosis.

# Introduction

- Provide clinical background of ABR and
  its importance.
- Problem statement: limitations of current
  ABR datasets (scarcity, noise, imbalance).
- Existing work: synthetic data in EEG/ECG,
  limited ABR studies.
- Contributions of this work: novel model,
  static parameter conditioning, peak-aware loss, robust evaluation.

# Related Work

- Generative models in biomedical signals
  (EEG, ECG, ABR if available).
- Diffusion models for time series.
- Transformer hybrids.
- Peak/event modeling in sparse medical
  signals.
- Highlight novelty gap compared to prior
  work.

# Methods

- Dataset: source, size, parameters,
  preprocessing, train/val/test split, ethics.
- Model Architecture: baseline models vs
  final hybrid model, static parameter embedding, peak-aware loss.
- Training Strategy: loss functions,
  optimization, hyperparameters, hardware.
- Evaluation Metrics: numerical (MSE, DTW),
  signal quality (SNR, PSD), clinical (peak accuracy, latency error),
  distributional similarity (UMAP/t-SNE).

# Results

- Reconstruction results: real vs reconstructed
  plots.
- Generation results: synthetic vs real
  samples.
- Quantitative metrics tables.
- Peak analysis: latency/amplitude
  accuracy.
- Static parameter variation experiments.
- Ablation studies: effect of removing
  components.

# Discussion

- Interpret results: long-range vs
  short-term dependencies, parameter conditioning effects.
- Clinical impact: data augmentation for
  diagnostics.
- Comparison with prior work.
- Limitations: dataset size, rare peak
  patterns, extreme noise.
- Future work: more robust denoising,
  larger datasets, multi-modal extensions.

# Conclusion

- Summarize contributions: first hybrid
  model for ABR, clinically meaningful synthetic signals, enhanced diagnostic
  potential.
- Future direction: multi-modal extensions,
  real-time applications.

# Acknowledgements

- Funding sources (e.g., TÜBİTAK).
- Supervisors, collaborators, lab
  contributions.

# References

- Follow target journal format (IEEE,
  Elsevier, Vancouver, etc.).
- Include ABR literature, generative
  models, diffusion models, SSMs.

# Supplementary Material

- Additional generated samples.
- Extended ablation results.
- Model code repository (if allowed).

# 📊 1. Likelihood of Q1

Publication

### Strengths that make Q1 publication plausible:

·       **Novelty**: Synthetic signal generation for ABR is almost
unexplored, compared to ECG/EEG. A “first-of-its-kind” claim is attractive.

·        **Methodological
depth** **: Using ****Diffusion + S4 + Transformer hybrid** and **static parameter conditioning** is
cutting-edge and goes beyond standard CVAEs or GANs.

·       **Clinical importance**: ABR is a diagnostic cornerstone
(especially newborn hearing screening), so improving datasets has medical
relevance.

·       **Technical–clinical bridge**: Journals love when
engineering meets real clinical need.

### Challenges that reduce chances:

·       **Dataset limitations**: If your dataset is single-center,
relatively small, or not publicly available, reviewers may flag lack of
generalizability.

·       **Validation gap**: If evaluation is only numerical (MSE,
DTW), but lacks **clinical validation** (e.g., real
audiologists testing usability), it might not pass in a Q1 medical/clinical
journal.

·       **Positioning**: If written too much like a machine learning
methods paper, it may get rejected by medical journals. If written too much
like a clinical paper, CS journals may say “not enough novelty.”

### Baseline probability:

·       **If submitted ****as is (technical novelty + small dataset, no
clinical validation)** → **~20–30% acceptance** in a lower Q1 engineering journal (e.g.,  *IEEE Transactions on
Neural Systems and Rehabilitation Engineering* **).**

·       **With ****stronger validation, ablations, and clinical framing** → **50–60%** in a mid/upper-tier Q1 ( *IEEE
JBHI, Frontiers in Neuroscience, Neural Networks* **).**

·       **With ****multi-institution dataset + real clinician validation +
open-source release** → **>70%**
chance at a **top-tier Q1** ( *Nature Scientific
Reports, Medical Image Analysis, NPJ Digital Medicine* **).**

---

# 🚀 2. How to Enhance the

Project to Maximize Q1 Likelihood

### A. Data & Clinical Validation

·       🔑
**Multi-center dataset**: If possible, collaborate
with at least one additional clinic to show generalizability.

·       👩‍⚕️
**Expert evaluation**: Ask audiologists to rate
synthetic vs real ABRs blindly (realism, interpretability). Include inter-rater
agreement.

·       📈
**Diagnostic task augmentation**: Train a classifier
(e.g., hearing loss detection) with real-only vs real+synthetic. Show that
synthetic data improves accuracy.

### B. Technical Enhancements

·       🌀
**Peak-aware modeling**: Make peak prediction central,
not auxiliary. Show the model can **faithfully reproduce
latencies & amplitudes**.

·       🔄
**Causal conditioning experiments**: Demonstrate how
changing static parameters (age, stimulus rate, FMP) produces **clinically
valid waveform changes**.

·       📊
**Robust evaluation metrics**: Add  *Fréchet Distance
for Time Series (FDTW)* , spectral coherence, and statistical similarity
tests (Kolmogorov–Smirnov).

·       🧩
**Ablation studies**: Compare CVAE, GAN, pure
Diffusion, S4-only, Transformer-only, and your hybrid. Q1 journals love clear
demonstrations of “why our model is better.”

### C. Framing & Positioning

·       🎯
**Engineering Q1 journals (IEEE, Neural Networks)**:
Emphasize model novelty and generative design.

·       🎯
**Medical/clinical Q1 journals (Frontiers, Nature Digital
Medicine)**: Emphasize clinical utility, data scarcity, diagnostic
improvement.

·       👉
Strategy: **Write dual narrative**: (1) strong ML
innovation, (2) clear clinical impact.

### D. Reproducibility & Openness

·       📂
**Open-source code + synthetic dataset release** (or
anonymized subset). Journals are increasingly requiring this.

·       📘
**Detailed reproducibility checklist**: show
hyperparameters, preprocessing steps, architecture diagrams.

·       This
alone can move a paper from a mid-tier reject to a Q1 acceptance.

### E. Writing & Visuals

·       📊
**High-quality figures**: side-by-side plots (real vs
synthetic, parameter variation, peak markings).

·       🧠
**Conceptual diagrams**: show how static parameters
affect waveform morphology.

·       ✍️
**Polished narrative**: emphasize “solves scarcity,
improves diagnostics, opens new research directions.”

# Paper B —** **

# Counterfactual & Causal Conditioning for ABR:

Peak-Aware Diffusion with Static Interventions

**Tagline:** Turn your
generator into a **counterfactual simulator**:
“what changes in the waveform when age/intensity/rate change?” and **validate physiologically**.

## Core Thesis

Introduce a **causal-aware, peak-aware
diffusion** that takes static parameters (age, stimulus rate,
intensity, polarity, FMP) and supports **interventional
generation** (do-operations). Validate that counterfactuals
obey **known physiological regularities**
(e.g., intensity ↑ → latency ↓; aging → latency ↑).

## What to add/change in the project

·       **Causal conditioning block**: e.g., FiLM/Adapter on
S4+Transformer denoiser with **separate “do() head”**
that disentangles observational vs interventional conditioning.

·       **Regularizers**: Monotonicity or cycle-consistency losses
for specific parameter–morphology relations (soft constraints).

·       **Peak-physics priors**: Lightweight priors tying
intensity/rate to expected latency distributions.

·       **Evaluation protocol**: Protocolized interventions—change
one variable while others fixed—and **test for expected trends**.

## Key Experiments

·       **Intervention curves**: Plot latency/amplitude vs
manipulated parameter; check monotonicity/shape vs literature.

·       **Counterfactual faithfulness**: Nearest-neighbor matching
in static-space to compare generated vs real physiological trends.

·       **Identifiability stress-tests**: Randomize/permute static
labels to show performance collapse (control).

## Figures / Tables

·       Intervention
grids (e.g., 4×4 panels): intensity × rate → waveform & peak markers.

·       Latency–intensity
scatter with trendlines for real vs synthetic counterfactuals.

·       Ablation:
remove peak-aware loss / remove monotone regularizer.

## Likely Venues

·        **Neural
Networks, Pattern Recognition, IEEE TSP** **, ****IEEE JBHI** (methods-heavy).

·       **If you generalize beyond ABR to a ** **causal time-series
generation framework** **: ** **ICLR/ICML/NeurIPS (workshop
→ main track if strong)** **.**

---
